Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lapatinib plus capecitabine versus capecitabine in refractory advanced or metastatic breast cancer
2004-001456-36Phase 3Completed
- Sponsor
- GSK
- Start
- Dec 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of lapatinib in breast cancer (2 arms), sponsored by GSK. Started Dec 2005; status: completed.
02
Drugs
lapatinib
03
Conditions
breast cancer
Beyond the preview
Go deeper on 2004-001456-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-001456-36.